DCN Dx Announces Call for Poster Abstracts for Advanced Lateral Flow Conference 2025 - Premier Diagnostics Event Returns to La Jolla

Researchers invited to showcase studies at premier lateral flow diagnostics event

LA JOLLA, Calif., April 30, 2025 /PRNewswire/ -- The Advanced Lateral Flow Conference (ALFC) is now accepting applications for poster presentations at its 2025 event, taking place October 14-15, 2025, at the Hilton La Jolla Torrey Pines in La Jolla, California. ALFC is the global meeting point for professionals across the rapid diagnostics ecosystem—including funders, regulatory leads, founders, scientists, engineers, and commercial teams—looking to exchange insights and accelerate progress in rapid diagnostics.

The ALFC poster session offers a chance to share new research, early-stage development data, technical lessons, or field-based findings with a highly engaged community of diagnostics professionals. Whether you're showcasing scientific validation, novel applications, scale-up experience, or regulatory approaches, posters at ALFC are a conversation starter, designed to drive practical discussion and spark new collaborations.

The deadline to submit abstracts is June 30, 2025.

This year's theme, Catalyzing Growth: Tech Advancements, Funding, and Regulatory Roadmaps in LFA, focuses on the real-world challenges of building and scaling diagnostics, from securing investment and navigating regulation to designing for manufacturability and proving market fit.

Relevant topics include:

• Funding & Investment Strategies – From early-stage capital to milestone-based deals and non-dilutive funding
• Commercial Strategy & Market Access – Pricing, reimbursement, and go-to-market decisions
• Product Development & Scale-Up – Technology transfer, cost modeling, design for manufacturing
• Regulatory & Risk Management – FDA, IVDR, global compliance, and risk-based planning
• Emerging Use Cases – Applications in AMR, veterinary, environmental, pharma, and low-resource markets

Submission Guidelines:

Your abstract should clearly state:

• What you're presenting and why it matters
• What data or experience supports your conclusions
• What your peers can take away from your work

We welcome a range of contributions, from research findings to product development insights, case studies, and implementation outcomes. Although commercial content is welcon, submissions must be original, not previously published, and free from advertising.

To submit your poster abstract, visit alfc2025.com.

About the Advanced Lateral Flow Conference

The Advanced Lateral Flow Conference (ALFC), presented by DCN Dx, is the leading global event for lateral flow diagnostic developers, manufacturers, and those driving their commercial success. This annual conference delivers cutting-edge insights through expert-led sessions and provides a platform for researchers and developers to exchange ideas and innovations. Attendees gain practical insights to advance their businesses, deepen their knowledge of rapid diagnostics, and connect with leading minds shaping the future of point-of-care testing. To learn more about ALFC, visit alfc2025.com.

About DCN Dx

DCN Dx, based in Carlsbad, California, specializes in lateral flow diagnostics development and manufacturing, and IVD regulatory consulting and clinical research. DCN Dx's multidisciplinary CDMO specializes in creating tailored assay systems, consumables, and instruments for point-of-use applications, with a particular expertise in lateral flow assays. Their clinical research services group specializes in the planning, execution, and oversight of IVD clinical trials, inclusive of clinical operations, data management, and biostatistics, and regulatory services.

DCN Dx's personalized approach to IVD product development and clinical trials has supported hundreds of programs and clients. They can oversee every stage from concept to assay development and platform integration, through clinical trials to manufacturing or only handle the aspects you request. In addition to lateral flow assays, DCN Dx's clinical research expertise extends to any in vitro diagnostic, all with a focus on innovation, usability, and performance.

With a commitment to quality, customer satisfaction, and industry-leading expertise, DCN Dx is setting the benchmark for excellence in IVD services. To learn more about how we can support your diagnostic needs, visit dcndx.com.

MEDIA CONTACT
Mitzi Rettinger
Chief Revenue Officer, DCN Dx
Main: (760) 804-3886
Mobile: (512) 431-5836
[email protected]

SOURCE DCN Dx